ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,305,725 | -9.8% | 1,688,887 | +0.8% | 0.01% | -10.0% |
| Q2 2023 | $52,438,204 | +13.9% | 1,675,342 | +2.5% | 0.01% | +11.1% |
| Q1 2023 | $46,057,667 | +9.1% | 1,633,830 | +1.2% | 0.01% | 0.0% |
| Q4 2022 | $42,197,833 | +18.0% | 1,614,919 | +0.8% | 0.01% | +12.5% |
| Q3 2022 | $35,762,000 | -25.7% | 1,601,550 | -0.8% | 0.01% | -20.0% |
| Q2 2022 | $48,108,000 | +12.0% | 1,614,879 | -1.1% | 0.01% | +25.0% |
| Q1 2022 | $42,953,000 | +7.7% | 1,632,582 | -4.8% | 0.01% | +14.3% |
| Q4 2021 | $39,881,000 | -25.9% | 1,714,561 | -1.7% | 0.01% | -30.0% |
| Q3 2021 | $53,813,000 | +23.1% | 1,744,930 | -2.2% | 0.01% | +25.0% |
| Q2 2021 | $43,729,000 | +209.4% | 1,783,349 | +135.7% | 0.01% | +166.7% |
| Q1 2021 | $14,134,000 | -4.1% | 756,649 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $14,738,000 | +18.5% | 738,725 | -1.6% | 0.00% | 0.0% |
| Q3 2020 | $12,435,000 | -18.1% | 750,493 | -4.1% | 0.00% | -25.0% |
| Q2 2020 | $15,183,000 | +31.4% | 782,442 | -2.3% | 0.00% | +33.3% |
| Q1 2020 | $11,554,000 | -23.1% | 801,248 | +8.7% | 0.00% | 0.0% |
| Q4 2019 | $15,030,000 | -16.8% | 736,832 | -20.4% | 0.00% | -25.0% |
| Q3 2019 | $18,067,000 | -14.1% | 926,042 | -0.7% | 0.00% | -20.0% |
| Q2 2019 | $21,022,000 | -37.3% | 932,643 | +1.6% | 0.01% | -37.5% |
| Q1 2019 | $33,505,000 | +24.2% | 918,192 | +0.5% | 0.01% | 0.0% |
| Q4 2018 | $26,970,000 | -25.7% | 913,916 | +6.8% | 0.01% | -11.1% |
| Q3 2018 | $36,305,000 | +0.7% | 855,472 | -2.3% | 0.01% | 0.0% |
| Q2 2018 | $36,056,000 | -26.9% | 876,000 | +3.0% | 0.01% | -30.8% |
| Q1 2018 | $49,293,000 | +4.9% | 850,474 | -1.0% | 0.01% | +8.3% |
| Q4 2017 | $47,000,000 | +7.7% | 858,753 | +0.1% | 0.01% | +9.1% |
| Q3 2017 | $43,636,000 | -11.9% | 858,303 | +0.4% | 0.01% | -21.4% |
| Q2 2017 | $49,554,000 | +0.0% | 854,816 | +0.9% | 0.01% | 0.0% |
| Q1 2017 | $49,548,000 | +7.9% | 846,971 | +2.5% | 0.01% | 0.0% |
| Q4 2016 | $45,927,000 | +21.0% | 826,343 | +2.4% | 0.01% | +16.7% |
| Q3 2016 | $37,943,000 | +13.3% | 806,807 | +4.1% | 0.01% | +9.1% |
| Q2 2016 | $33,486,000 | +28.3% | 774,784 | +5.8% | 0.01% | +22.2% |
| Q1 2016 | $26,108,000 | -53.2% | 731,978 | +4.2% | 0.01% | -50.0% |
| Q4 2015 | $55,770,000 | +8.3% | 702,547 | -20.0% | 0.02% | +5.9% |
| Q3 2015 | $51,515,000 | -10.4% | 878,043 | -1.7% | 0.02% | 0.0% |
| Q2 2015 | $57,469,000 | -5.4% | 893,212 | -10.3% | 0.02% | -5.6% |
| Q1 2015 | $60,737,000 | +37.2% | 996,203 | +31.8% | 0.02% | +38.5% |
| Q4 2014 | $44,271,000 | +51.8% | 755,994 | +11.1% | 0.01% | +44.4% |
| Q3 2014 | $29,161,000 | -4.1% | 680,231 | +12.6% | 0.01% | 0.0% |
| Q2 2014 | $30,416,000 | +13.1% | 604,314 | -0.9% | 0.01% | +12.5% |
| Q1 2014 | $26,892,000 | +10.2% | 609,939 | +1.6% | 0.01% | 0.0% |
| Q4 2013 | $24,406,000 | +23.4% | 600,244 | +2.0% | 0.01% | +14.3% |
| Q3 2013 | $19,777,000 | -49.0% | 588,260 | -56.5% | 0.01% | -50.0% |
| Q2 2013 | $38,770,000 | – | 1,351,804 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |